[go: up one dir, main page]

ZA200108673B - Treatment of autoimmune diseases with antagonists which bind to B cell surface markers. - Google Patents

Treatment of autoimmune diseases with antagonists which bind to B cell surface markers.

Info

Publication number
ZA200108673B
ZA200108673B ZA200108673A ZA200108673A ZA200108673B ZA 200108673 B ZA200108673 B ZA 200108673B ZA 200108673 A ZA200108673 A ZA 200108673A ZA 200108673 A ZA200108673 A ZA 200108673A ZA 200108673 B ZA200108673 B ZA 200108673B
Authority
ZA
South Africa
Prior art keywords
antagonists
bind
treatment
cell surface
autoimmune diseases
Prior art date
Application number
ZA200108673A
Inventor
John G Curd
Lori A Kunkel
Antonio J Grillo-Lopez
Original Assignee
Genentech Inc
Idec Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc, Idec Pharmaceuticals Inc filed Critical Genentech Inc
Publication of ZA200108673B publication Critical patent/ZA200108673B/en

Links

ZA200108673A 1999-05-07 2001-10-22 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers. ZA200108673B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13301899P 1999-05-07 1999-05-07

Publications (1)

Publication Number Publication Date
ZA200108673B true ZA200108673B (en) 2002-12-24

Family

ID=27733617

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200108673A ZA200108673B (en) 1999-05-07 2001-10-22 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers.

Country Status (2)

Country Link
CN (1) CN101254302B (en)
ZA (1) ZA200108673B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101897961B (en) * 2010-04-20 2013-03-27 华中科技大学同济医学院附属协和医院 Preparation method for B cell CD 22 extracellular inhibitive peptide fragment B2285 vaccines
CA2795823C (en) * 2010-04-28 2019-06-04 Xincheng Zheng Cd24 proteins and use thereof in treating rheumatoid arthritis
PL3178929T3 (en) * 2014-08-06 2021-12-20 Astellas Pharma Inc. NEW ANTIBODY AGAINST HUMAN IG (BETA)
CN107488230B (en) * 2017-09-01 2019-01-18 浙江大学 A kind of antibody, encoding gene and the application of the extracellular end protein of anti-human CD79a

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686072A (en) * 1992-06-17 1997-11-11 Board Of Regents, The University Of Texas Epitope-specific monoclonal antibodies and immunotoxins and uses thereof
US5417972A (en) * 1993-08-02 1995-05-23 The Board Of Trustees Of The Leland Stanford Junior University Method of killing B-cells in a complement independent and an ADCC independent manner using antibodies which specifically bind CDIM

Also Published As

Publication number Publication date
CN101254302A (en) 2008-09-03
CN101254302B (en) 2011-05-11

Similar Documents

Publication Publication Date Title
EP1642596A3 (en) Treatment of autoimmune diseases with antagonists which bind to B cell surface markers
HU0003386D0 (en) Use of crf antagonists
MA25530A1 (en) DIAMINOTHIAZOLES AND THEIR USE TO INHIBIT PROTEIN KINASES.
EP1213397A4 (en) STRUCTURAL BODY ACCOUPLE
EP1385937A4 (en) Delivery of polynucleotide agents to the central nervous sysstem
MXPA02002898A (en) Pyrazolopyrimidines as therapeutic agents.
AU140483S (en) Outsole
GB0009917D0 (en) Forming interconnects
EP1212568A4 (en) Utility lighter
GB2366831B (en) Water Butts
MXPA01012580A (en) Predicting proximity to coke formation.
SI1176981T1 (en) Treatment of autoimmune diseases with antagonists which bind to b cell surface markers
ZA200108673B (en) Treatment of autoimmune diseases with antagonists which bind to B cell surface markers.
GB0003335D0 (en) Roofing construction
ZA989615B (en) The use of TNF antagonists as drugs for treating septic 39disorders.
GB9904436D0 (en) Artificial flooring
ZA200109120B (en) Use of Arylalkanoylpyridazines.
DE60023645D1 (en) INVISIBLE CODING FOR CHARGING TAX
GB0104920D0 (en) Improvements to membrane lined gutters
ZA200202868B (en) Use of thienopyrimidines.
EP1218036A4 (en) Cell based assay
TW378729U (en) Improved structure of the water stopper
GB9926462D0 (en) Slate nib
PL331571A1 (en) Structural roofing
AU2001263307A8 (en) Haplotypes of the ccr3 gene